Chu Brest
Brest, 29609, France
NCT Number: NCT06668246
This study aimed to compare refractive measurements using Vision-S™ 700, an immersive and compact phoropter with a tunable-focus lens, and Vision-R™ 800, a phoropter with a tunable-focus lens without immersion, with cycloplegic refraction serving as the gold-standard.
This a retrospective study aimed to enroll 41 children, aged 6 to 16 years, who underwent refractive assessments with Vision-S™ 700, Vision-R™ 800, and cycloplegic refraction. The primary objective involves a comparison of the spherical equivalent between both devices and compared to cycloplegic refraction. Secondary outcomes include the analysis of astigmatism components (J0° and J45°) and subgroup analyses in myopic and hyperopic children.
Looking for future studies?
Notify Me6 year–16 year
All sexes
Observational
Brest, 29609, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
As of today, no published clinical studies have been conducted with the Vision-S™ 700 neither Vision R 800
Time frame: Day 1
The primary outcome of this study was to compare the spherical equivalent, obtained using two different devices: Vision-S™ 700, an immersive phoropter with a tunable-focus lens, and Vision-R™ 800, a phoropter with a tunable-focus lens without immersion. The study aimed to assess the overall agreement of these measurements with cycloplegic refraction, considered the gold standard in this context.
University Hospital, Brest
Other
Performance of Refractometers With Self-adjusting Lenses Compared to Cycloplegia in Children
Acronym: REFRALENS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05010512
Ametropia, Eye Diseases
Orlando, Florida, United States
View Trial DetailsNCT04908488
Ametropia, Astigmatism
Los Angeles, California, United States
View Trial DetailsNCT04532099
Ametropia, Eye Diseases
Longwood, Florida, United States
View Trial DetailsNCT03034928
Ametropia, Eye Diseases
Johns Creek, Georgia, United States
View Trial Details